CIK 0001831915 · Accelerated filer
Cytek Biosciences, Inc.
Sign in to watch- Ticker
- CTKB
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472547526
- Phone
- (877) 922-9835
- Business address
- 47215 LAKEVIEW BOULEVARD, FREMONT, CA, 94538
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-07 | Jiang Wenbin President and CEO | Sale | −1,200 | $13.79 | $17K | 7,936,040 |
| 2022-03-07 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +337,901 | $12.61 | $4.3M | 11,916,845 |
| 2022-03-04 | Jiang Wenbin President and CEO | Option exercise | +66,665 | $0.25 | $17K | 7,956,040 |
| 2022-03-04 | Jiang Wenbin President and CEO | Option exercise · Stock Option (Right to Buy) | −66,665 | 0 | ||
| 2022-03-04 | Barnett Valerie General Counsel | Option exercise | +10,500 | $4.71 | $49K | 12,400 |
| 2022-03-04 | Barnett Valerie General Counsel | Option exercise · Stock Option (Right to Buy) | −10,500 | 122,830 | ||
| 2022-03-04 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +63,662 | $12.99 | $827K | 11,578,944 |
| 2022-03-02 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +138,255 | $12.89 | $1.8M | 11,515,282 |
| 2022-03-01 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +294,864 | $12.98 | $3.8M | 11,377,027 |
| 2022-02-28 | Yan Ming Chief Technology Officer | Grant or award · Stock Option (Right to Buy) | +47,841 | 47,841 | ||
| 2022-02-28 | Yan Ming Chief Technology Officer | Grant or award · Restricted Stock Units | +31,708 | 31,708 | ||
| 2022-02-28 | Poirson Allen SVP Marketing and Corp. Dev. | Grant or award · Stock Option (Right to Buy) | +19,081 | 19,081 | ||
| 2022-02-28 | Poirson Allen SVP Marketing and Corp. Dev. | Grant or award · Restricted Stock Units | +12,646 | 12,646 | ||
| 2022-02-28 | Jiang Wenbin President and CEO | Grant or award · Stock Option (Right to Buy) | +163,158 | 163,158 | ||
| 2022-02-28 | Jiang Wenbin President and CEO | Grant or award · Restricted Stock Units | +108,137 | 108,137 | ||
| 2022-02-28 | Jeanmonod Patrik Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +42,310 | 42,310 | ||
| 2022-02-28 | Jeanmonod Patrik Chief Financial Officer | Grant or award · Restricted Stock Units | +28,042 | 28,042 | ||
| 2022-02-28 | Barnett Valerie General Counsel | Grant or award · Stock Option (Right to Buy) | +48,671 | 48,671 | ||
| 2022-02-28 | Barnett Valerie General Counsel | Grant or award · Restricted Stock Units | +32,258 | 32,258 | ||
| 2022-02-28 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +8,746 | $12.97 | $113K | 11,082,163 |
Page 47 of 49 · 980 trades